Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary

Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – Targeted T Cell Receptor

Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein

CARBIOS and Hündgen Enter Supply Agreement for World’s First PET Biorecycling Plant

InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024

Newron Announces Positive Top-Line Results from Potentially Pivotal Phase II/III Study 008A with Evenamide in Schizophrenia Patients

Medigene AG Reports Financial Results and Business Update for Q1 2024

CARBIOS Celebrates the Groundbreaking of its PET Biorecycling Plant, a World First, with its Partners

Affluent Medical: 2023 Financial Results and Update on Clinical Activities under Development

Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic